The only indication that there may be risks associated with taking the companies products came in the last line of a long written disclaimer at the end of the ad: See website for details and important safety information. (A similar disclaimer appears at the end of the Hims ad focusing on its ED medication.) Since the controversy over the Super Bowl ad, Hims and Hers have included a disclaimer in some of their ads regarding how their compounded weight-loss products have not been approved by the FDA and require an online consultation with a licensed provided who will determine if a prescription is appropriate. But the disclaimer doesnt appear everywhere and it still refers consumers to a company website for important safety information. As for the other telehealth companies mentioned earlier, Willow does not disclose any side effects associated with its compounded GLP-1 products in the social media post shown above and requires that consumers scroll more than halfway down product pages to learn about potential health risks

Gentle Cosmetic Care: Formulated for cosmetic use, this scalp & hair serum is fragrance-free, paraben-free, dye-free, and vegan-friendly
If you experience progressive numbness, meaningful weakness, frequent falls, or new bowel or bladder issues, seek medical evaluation promptly
Legal, sicher und planbar geht der Bezug in Deutschland nur ber die rztliche Verordnung und die Apotheke
Both the 2016 consensus statement of the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) on management of type 2 diabetes and the 2016 American Diabetes Association (ADA) standards recommend adding on GLP-1 RAs to patients not meeting treatment goals with basal insulin